Pune, June 22, 2022 (GLOBE NEWSWIRE) — Liquid Biopsy Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Liquid Biopsy Market Forecast to 2030, published by Market Data Centre, The Liquid Biopsy Market is projected to grow at a solid pace during the forecast period. The presence of key players in the ecosystem has led to a compsetitive and diverse market. The advancement of digital transformation initiatives across multiple industries is expected to drive the worldwide Liquid Biopsy Market during the study period.
This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. This report provides a detailed historical analysis of the global Liquid Biopsy Market from 2017-to 2021 and provides extensive market forecasts from 2022-to 2030 by region/country and subsectors. The report covers the revenue, sales volume, price, historical growth, and future perspectives in the Liquid Biopsy Market .
The Global Liquid Biopsy Market size is projected to grow from USD 8.45 Billion in 2022 to USD 21.27 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.89% during the forecast period (2022-2030).
Download Free Sample PDF@ https://www.marketdatacentre.com/samplepdf/13497
List of the key players of the global liquid biopsy market profiled are:
- QIAGEN
- Myriad Genetics, Inc.
- BIOCEPT,…
